August 29, 2012

Community Specialty Pharmacy Network has appointed a former Bayer Pharmaceuticals executive to serve as the organization's VP managed care relations.

August 29, 2012

The Food and Drug Administration has granted priority review to a supplemental new drug application for a drug developed by Janssen Research and Development.

August 29, 2012

MedPro Rx has earned one of the top spots in the Top 300 Small Businesses of the South competition hosted by Business Leader magazine.

August 29, 2012

The Food and Drug Administration has approved a supplemental new drug application for an opioid analgesic to treat diabetes-related pain.

August 28, 2012

While the growth in healthcare costs remains a threat in the United States, the growth in drug expenditures is moderating, but numerous opportunities exist for retail, according to a speech delivered Tuesday morning at the National Association of Chain Drug Stores' 2012 Pharmacy and Technology Conference in Denver by Doug Long, VP industry relations of healthcare industry research firm IMS Health.

August 28, 2012

The Food and Drug Administration has approved a new once-a-day combination pill to treat HIV-1 infection in adults who have never been treated for HIV infection.

August 28, 2012

Merz announced it has acquired a medication designed to treat a condition associated with such neurologic conditions as cerebral palsy.

August 27, 2012

The whole purpose of Pharmacist Society is to bring together the myriad stakeholders in the field, so it's only natural that specialty pharmacy also should have a place.

August 27, 2012

Diplomat Specialty Pharmacy has earned a spot on Inc. magazine's annual ranking of the fastest-growing private companies in America.

August 27, 2012

Genzyme announced it has received a refuse-to-file letter from the Food and Drug Administration in response to the drug maker's supplemental biologics license application for the approval of Lemtrada (alemtuzumab) as a treatment for relapsing multiple sclerosis.

August 23, 2012

A drug maker that specializes in pain medications started the third late-stage trial of a drug for treating pain in patients who have undergone certain surgeries.

August 23, 2012

A division of Johnson & Johnson has started a late-stage clinical trial program for a drug for rheumatoid arthritis under a partnership with British drug maker GlaxoSmithKline.

August 22, 2012

The Food and Drug Administration has postponed its decision whether or not to approve an experimental arthritis drug made by Pfizer, the drug maker said.

August 21, 2012

The largest nonprofit organization focused on HIV and AIDS has acquired a group of specialty pharmacies.

August 21, 2012

The Food and Drug Administration has approved a drug made by Reckitt Benckiser Pharmaceuticals for treating addiction to opioid drugs, the drug maker said.

August 20, 2012

A network of more than 200 specialty pharmacies has joined a provider of direct-to-patient medication adherence programs.

August 17, 2012

They say hindsight is 20/20. With the Supreme Court’s ruling on healthcare reform, the luxury of looking back shows that the National Association of Chain Drug Stores and allies took the right course to battle the pharmacy Medicaid cuts of the Deficit Reduction Act. What we learned should inspire pharmacy to remain tenacious in its continued advocacy on this issue and in confronting all other challenges.

August 17, 2012

Armada Health Care has integrated its ApproveRx prior authorization system with a pharmacy software system made by KeyCentrix, the companies said.

August 17, 2012

A former CVS executive has been appointed to a top position at a company that provides pharmacy services to the long-term care industry.

August 15, 2012

Children who take a class of opioid pain relievers after certain surgeries may be at risk of death, the Food and Drug Administration warned Wednesday.

August 15, 2012

A division of Teva Pharmaceutical Industries has launched a generic chemotherapy drug, the company said.

August 14, 2012

Drug maker Mylan will pass out free EpiPen injectors to children in schools, the company said Tuesday.

August 13, 2012

Regulators have approved a biotech drug made by Genentech for treating a complication related to diabetes.

August 13, 2012

An experimental drug therapy under development by Novartis for liver transplant patients appears to provide similar efficacy and better kidney function, compared with a drug made by Astellas Pharma, according to results of a late-stage clinical trial.